WELLS FARGO & COMPANY/MN - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACK and the CUSIP is 590328209. A total of 65 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.4%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$26,794
-51.0%
2,173
-51.1%
0.00%
Q2 2023$54,686
+2517.8%
4,446
+2515.3%
0.00%
Q1 2023$2,089
+8.5%
170
+1.2%
0.00%
Q4 2022$1,925
+92.5%
168
-29.7%
0.00%
Q3 2022$1,000239
+95.9%
0.00%
Q2 2022$0122
+5.2%
0.00%
Q1 2022$01160.0%0.00%
Q4 2021$01160.0%0.00%
Q3 2021$0
-100.0%
116
-14.7%
0.00%
Q2 2021$1,0000.0%136
-0.7%
0.00%
Q1 2021$1,0000.0%1370.0%0.00%
Q4 2020$1,000137
+3.8%
0.00%
Q3 2020$0132
+3.1%
0.00%
Q2 2020$01280.0%0.00%
Q1 2020$0128
+156.0%
0.00%
Q4 2019$0500.0%0.00%
Q3 2019$0500.0%0.00%
Q2 2019$0500.0%0.00%
Q1 2019$0
-100.0%
50
-99.7%
0.00%
Q1 2018$151,000
-19.3%
18,837
+3.0%
0.00%
Q4 2017$187,000
+125.3%
18,287
+220.5%
0.00%
Q3 2017$83,0005,7060.00%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
Western Standard LLC 1,894,013$23,353,18021.09%
Newtyn Management, LLC 1,873,694$23,102,6475.70%
Sio Capital Management, LLC 288,466$3,556,7861.10%
Madison Avenue Partners, LP 553,085$6,819,5380.97%
WITTENBERG INVESTMENT MANAGEMENT, INC. 209,739$2,5860.95%
Indaba Capital Management, L.P. 136,802$1,686,7690.50%
Sepio Capital, LP 306,680$3,781,3640.33%
Yakira Capital Management, Inc. 54,118$667,2750.18%
Centiva Capital, LP 187,803$2,315,6110.05%
FIFTH LANE CAPITAL, LP 10,929$134,4270.05%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders